Zaloguj się

Gotowe bibliografie tematyczne / Beta 2-glycoprotein I / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Beta 2-glycoprotein I.

Artykuły w czasopismach na temat „Beta 2-glycoprotein I”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 18 lutego 2022

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Beta 2-glycoprotein I”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Inanc, M. "beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?" Rheumatology 36, no. 12 (December 1, 1997): 1247–57. http://dx.doi.org/10.1093/rheumatology/36.12.1247.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Schousboe, I. "beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway." Blood 66, no. 5 (November 1, 1985): 1086–91. http://dx.doi.org/10.1182/blood.v66.5.1086.1086.

Pełny tekst źródła

Streszczenie:

Abstract The general hypothesis for the biological function of beta 2- glycoprotein I is that it neutralizes all negatively charged macromolecules that might enter the bloodstream and diminishes unwanted activation of the blood coagulation. In the present study we report that beta 2-glycoprotein I inhibits the activation of the contact phase system of the intrinsic pathway of blood coagulation. Activation was accomplished by an ellagic acid-phospholipid suspension (Cephotest) and measured by the appearance of amidolytic activity using the chromogenic substrate H-D-Pro-Phe-Arg-p-nitroanilide (S

Style APA, Harvard, Vancouver, ISO itp.

3

Schousboe, I. "beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway." Blood 66, no. 5 (November 1, 1985): 1086–91. http://dx.doi.org/10.1182/blood.v66.5.1086.bloodjournal6651086.

Pełny tekst źródła

Streszczenie:

The general hypothesis for the biological function of beta 2- glycoprotein I is that it neutralizes all negatively charged macromolecules that might enter the bloodstream and diminishes unwanted activation of the blood coagulation. In the present study we report that beta 2-glycoprotein I inhibits the activation of the contact phase system of the intrinsic pathway of blood coagulation. Activation was accomplished by an ellagic acid-phospholipid suspension (Cephotest) and measured by the appearance of amidolytic activity using the chromogenic substrate H-D-Pro-Phe-Arg-p-nitroanilide (S-2302). T

Style APA, Harvard, Vancouver, ISO itp.

4

Arad, Ariela, Richard A. Furie, Barbara C. Furie, and Bruce Furie. "Affinity-Purified Anti-Beta-2 Glycoprotein-1 Antibodies from a Patient with Lupus Anticoagulant-Associated Thrombosis Amplify Thrombus Formation in the Living Mouse." Blood 114, no. 22 (November 20, 2009): 146. http://dx.doi.org/10.1182/blood.v114.22.146.146.

Pełny tekst źródła

Streszczenie:

Abstract Abstract 146 Antiphospholipid syndrome (APS) is characterized by thrombosis, recurrent fetal loss and the presence of the lupus anticoagulant, anticardiolipin antibodies or anti-beta-2 glycoprotein 1 antibodies. Sera from patients with APS contain polyclonal antibodies that bind to various plasma proteins including beta-2 glycoprotein 1. Although beta-2 glycoprotein 1 antibodies have been well-documented as a biomarker for the diagnosis of APS, their direct role in the pathogenesis of thrombosis is unknown. Here, we have demonstrated using intravital microscopy that purified anti-beta

Style APA, Harvard, Vancouver, ISO itp.

5

Kertesz, Z., B. B. Yu, A. Steinkasserer, H. Haupt, A. Benham та R. B. Sim. "Characterization of binding of human β2-glycoprotein I to cardiolipin". Biochemical Journal 310, № 1 (15 серпня 1995): 315–21. http://dx.doi.org/10.1042/bj3100315.

Pełny tekst źródła

Streszczenie:

beta 2-Glycoprotein I-cardiolipin complexes are reported to be a target antigen for the binding of a subset of anti-phospholipid antibodies. The characteristics of binding of beta 2-glycoprotein I to cardiolipin are reported in this paper. Binding at neutral pH is specific, saturable, dependent on ionic strength and independent of bivalent cation. Binding at low pH is qualitatively different from that at neutral pH, and is not dependent on ionic strength. Denaturation of beta 2-glycoprotein I by heat inactivation and reduction/alkylation indicates that beta 2-glycoprotein I-cardiolipin interac

Style APA, Harvard, Vancouver, ISO itp.

6

Wittevrongel, C., M. Vanrusselt, M. Hoylaerts, J. Vermylen, and J. Arnout. "Beta-2-glycoprotein I Dependent Lupus Anticoagulants Form Stable Bivalent Antibody Beta-2-Glycoprotein I Complexes on Phospholipid Surfaces." Thrombosis and Haemostasis 79, no. 01 (1998): 79–86. http://dx.doi.org/10.1055/s-0037-1614224.

Pełny tekst źródła

Streszczenie:

SummaryThe precise mechanism by which Beta-2-glycoprotein I (β2GPI-) dependent lupus anticoagulants lengthen phospholipid-dependent clotting reactions is still poorly understood. In order to study this, murine monoclonal antibodies (moabs) against human β2GPI were raised. Eight of the 21 anti-β2GPI moabs, obtained from 2 fusions, fulfilled the criteria for lupus anticoagulant (LA) activity as tested with a variety of sensitive screening assays and confirmatory tests. Seven moabs did not influence any clotting test. The LA positive moabs were found to compete for similar or closely spaced epito

Style APA, Harvard, Vancouver, ISO itp.

7

Marai, Ibrahim, Angela Tincani, Genesio Balestrieri, and Yehuda Shoenfeld. "Anticardiolipin and anti-beta-2-glycoprotein I antibodies." Autoimmunity 38, no. 1 (February 2005): 33–38. http://dx.doi.org/10.1080/08916930400022608.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Božič, B., S. Čučnik, T. Kveder, and B. Rozman. "Avidity of anti-beta-2-glycoprotein I antibodies." Autoimmunity Reviews 4, no. 5 (June 2005): 303–8. http://dx.doi.org/10.1016/j.autrev.2005.01.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Meroni, P. L., D. Mari, D. Monti, R. Coppola, M. Capri, S. Salvioli, A. Tincani, R. Gerli, and C. Franceschi. "Anti-beta 2 glycoprotein I antibodies in centenarians." Experimental Gerontology 39, no. 10 (October 2004): 1459–65. http://dx.doi.org/10.1016/j.exger.2004.08.003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Matsuda, J., N. Saitoh, M. Gotoh, K. Gohchi, and M. Tsukamoto. "Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies." Annals of the Rheumatic Diseases 54, no. 1 (January 1, 1995): 73–75. http://dx.doi.org/10.1136/ard.54.1.73.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Brochado, Maria José Franco, José Fernando C. Figueiredo, Celso Teixeira Mendes-Junior, Paulo Louzada-Junior, Olivia Makiyama Kim, and Ana Maria Roselino. "Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy." Archives of Dermatological Research 302, no. 8 (February 7, 2010): 583–91. http://dx.doi.org/10.1007/s00403-010-1032-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

KABURAKI, Junichi, Masataka KUWANA, Mihoko YAMAMOTO, Shinichi KAWAI, Eiji MATSUURA, and Yasuo IKEDA. "Phospholipid-Dependent Anti-.BETA.2-Glycoprotein I (.BETA.2-GPI) Antibodies and Antiphospholipid Syndrome." Internal Medicine 35, no. 2 (1996): 105–10. http://dx.doi.org/10.2169/internalmedicine.35.105.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Norden, A. G. W., L. M. Fulcher, M. Lapsley, and F. V. Flynn. "Excretion of beta 2-glycoprotein I (apolipoprotein H) in renal tubular disease." Clinical Chemistry 37, no. 1 (January 1, 1991): 74–77. http://dx.doi.org/10.1093/clinchem/37.1.74.

Pełny tekst źródła

Streszczenie:

Abstract beta 2-Glycoprotein I (beta 2GI) was identified as a major urinary protein excreted by patients with several renal tubular diseases, including adult Fanconi syndrome, nephrocalcinosis associated with autoimmune diseases, Lowe's syndrome, and Dent's disease (a familial renal tubular disease). Sixteen patients excreted between 2 and 40 mg of beta 2GI per millimole of creatinine. In contrast, 18 healthy controls had undetectable amounts of beta 2GI in urine. Isoelectric focusing followed by immunoblotting demonstrated multiple forms of beta 2GI with pls between 6.4 and 8.2. These pls are

Style APA, Harvard, Vancouver, ISO itp.

14

Nakagawa, Hisako, Shinsuke Yasuda, and Tadaaki Miyazaki. "Novel Function of Beta 2 Glycoprotein I in Angiogenesis." Current Angiogenesis 3, no. 3 (March 11, 2015): 132–38. http://dx.doi.org/10.2174/2211552803666141125214938.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Miyakis, Spiros, Bill Giannakopoulos, and Steven A. Krilis. "Beta 2 glycoprotein I-function in health and disease." Thrombosis Research 114, no. 5-6 (January 2004): 335–46. http://dx.doi.org/10.1016/j.thromres.2004.07.017.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

EBELING, F., T. PETTERSSON, L. MUUKKONEN, E. VAHTERA, and V. RASI. "Beta‐2‐glycoprotein I antibodies in patients with thrombosis." Scandinavian Journal of Clinical and Laboratory Investigation 63, no. 2 (January 2003): 111–18. http://dx.doi.org/10.1080/00365510310002086.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Blanco, Manuel Serrano, Jose Angel KJA Martinez Flores 2, Dolores Perez, Jose Maria Morales, Javier Gainza, Roberto Marcen, Fernando Escuin, et al. "Pre-transplant antibodies IgA-anti Beta 2 Glycoprotein I." Transplantation 102, Supplement 7 (July 2018): S189. http://dx.doi.org/10.1097/01.tp.0000542834.31485.ac.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Balasubramanian, Krishnakumar, Jerald J. Killion, and Alan J. Schroit. "Estimation of Plasma Beta-2-Glycoprotein Levels by Competitive ELISA." Thrombosis Research 92, no. 2 (October 1998): 91–97. http://dx.doi.org/10.1016/s0049-3848(98)00115-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Brusch, Anna M. "Antiphospholipid antibodies: significance of anti-beta-2-glycoprotein i isotypes." Pathology 47 (2015): S40. http://dx.doi.org/10.1097/01.pat.0000461431.82122.d7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Artusi, C., S. Fumagalli, M. Oggioni, M. O. Borghi, C. Grossi, P. L. Meroni, F. Tedesco, and M. G. De Simoni. "AB0131 Tissue Beta 2 glycoprotein I in Brain Ischemic Injury." Annals of the Rheumatic Diseases 75, Suppl 2 (June 2016): 941.3–941. http://dx.doi.org/10.1136/annrheumdis-2016-eular.5315.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Blank, Miri, and Yehuda Shoenfeld. "Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations." Clinical Immunology 112, no. 2 (August 2004): 190–99. http://dx.doi.org/10.1016/j.clim.2004.02.018.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Passam, F. H., J. C. Qi, K. Tanaka, K. I. Matthaei, and S. A. Krilis. "In vivo modulation of angiogenesis by beta 2 glycoprotein I." Journal of Autoimmunity 35, no. 3 (November 2010): 232–40. http://dx.doi.org/10.1016/j.jaut.2010.06.013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Ebeling, Freja, Jari Pet�j�, Soile Alanko, Aune Hirvasniemi, Tarja Holm, Marja L�hde, Auli Nuutila, Helena Pesonen, Elina Vahtera, and Vesa Rasi. "Infant stroke and beta-2-glycoprotein 1 antibodies: six cases." European Journal of Pediatrics 162, no. 10 (October 1, 2003): 678–81. http://dx.doi.org/10.1007/s00431-003-1285-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Passam, Freda H., Soheila Rahgozar, Miao Qi, Mark J. Raftery, Jason W. H. Wong, Kumiko Tanaka, Yiannis Ioannou, et al. "Beta 2 glycoprotein I is a substrate of thiol oxidoreductases." Blood 116, no. 11 (September 16, 2010): 1995–97. http://dx.doi.org/10.1182/blood-2010-02-271494.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Roberts, G. P. "Characterization of the antigens recognized by two monoclonal antibodies reactive with basal-layer keratinocytes of human epidermis." Biochemical Journal 299, no. 3 (May 1, 1994): 659–64. http://dx.doi.org/10.1042/bj2990659.

Pełny tekst źródła

Streszczenie:

Two monoclonal antibodies, GR3 and GR4, reactive with the basal-layer keratinocytes of human epidermis, were derived by immunization of Balb/c mice with glycoproteins isolated from cultured keratinocytes by lectin-affinity chromatography. Immunoprecipitation of Triton X-100 extracts from human keratinocytes metabolically labelled with D-[1-14C]glucosamine revealed that GR3 recognized a major glycoprotein with migration properties identical with those of a glycoprotein (reduced form M(r) 126,000) which was previously shown to be implicated in intercellular adhesion [Roberts and Brunt (1985) Bio

Style APA, Harvard, Vancouver, ISO itp.

26

Joneckis, CC, RL Ackley, EP Orringer, EA Wayner, and LV Parise. "Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia." Blood 82, no. 12 (December 15, 1993): 3548–55. http://dx.doi.org/10.1182/blood.v82.12.3548.3548.

Pełny tekst źródła

Streszczenie:

Abstract The abnormal adherence of red blood cells, especially circulating reticulocytes (erythrocyte precursors), to the endothelium is believed to contribute to vascular occlusion observed in patients with sickle cell disease. Although several plasma proteins including von Willebrand factor and fibronectin have been proposed to mediate this adhesion, the mechanism of sickle cell adhesion to the endothelium remains unknown. Using flow cytometry, we screened sickle red blood cells with monoclonal antibodies (MoAbs) against known adhesion receptors and detected integrin subunits alpha 4 and bet

Style APA, Harvard, Vancouver, ISO itp.

27

Joneckis, CC, RL Ackley, EP Orringer, EA Wayner, and LV Parise. "Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia." Blood 82, no. 12 (December 15, 1993): 3548–55. http://dx.doi.org/10.1182/blood.v82.12.3548.bloodjournal82123548.

Pełny tekst źródła

Streszczenie:

The abnormal adherence of red blood cells, especially circulating reticulocytes (erythrocyte precursors), to the endothelium is believed to contribute to vascular occlusion observed in patients with sickle cell disease. Although several plasma proteins including von Willebrand factor and fibronectin have been proposed to mediate this adhesion, the mechanism of sickle cell adhesion to the endothelium remains unknown. Using flow cytometry, we screened sickle red blood cells with monoclonal antibodies (MoAbs) against known adhesion receptors and detected integrin subunits alpha 4 and beta 1 and t

Style APA, Harvard, Vancouver, ISO itp.

28

Buchholz, Ina, Peter Nestler, Susan Köppen, and Mihaela Delcea. "Lysine residues control the conformational dynamics of beta 2-glycoprotein I." Physical Chemistry Chemical Physics 20, no. 42 (2018): 26819–29. http://dx.doi.org/10.1039/c8cp03234c.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Gao, Pu-Jun. "Studies on specific interaction of beta-2-glycoprotein I with HBsAg." World Journal of Gastroenterology 9, no. 9 (2003): 2114. http://dx.doi.org/10.3748/wjg.v9.i9.2114.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Balestrieri, Genesio, Angela Tincani, Laura Spatola, Flavio Allegri, Enrica Prati, Roberto Cattaneo, Guido Valesini, Nicoletta Del Papa, and Pierluigi Meroni. "Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?" Lupus 4, no. 2 (April 1995): 122–30. http://dx.doi.org/10.1177/096120339500400208.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Wong, R. C. W., E. J. Favaloro, S. Adelstein, K. Baumgart, R. Bird, T. A. Brighton, M. Empson, et al. "Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting." Pathology 40, no. 1 (January 2008): 58–63. http://dx.doi.org/10.1080/00313020701717720.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Abinader, A., A. J. Hanly, and C. J. Lozada. "Catastrophic antiphospholipid syndrome associated with anti-beta-2- glycoprotein I IgA." Rheumatology 38, no. 1 (January 1, 1999): 84–85. http://dx.doi.org/10.1093/rheumatology/38.1.84.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Fiallo, Paolo, Carlo Tomasina, Andrea Clapasson, and Paolo P. Cardo. "Antibodies to Beta₂-Glycoprotein I in Ischemic Stroke." Cerebrovascular Diseases 10, no. 4 (2000): 293–97. http://dx.doi.org/10.1159/000016073.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Fleming, Sherry D. "Beta 2-glycoprotein I derived-peptides attenuate complement-mediated intestinal damage." Immunobiology 217, no. 11 (November 2012): 1141. http://dx.doi.org/10.1016/j.imbio.2012.08.035.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Antosik, P., B. Kempisty, M. Jackowska, D. Bukowska, M. Lianeri, KP Brussow, and M. Wozna. "The morphology of porcine oocytes is associated with zona pellucida glycoprotein 3 and integrin beta 2 protein levels--." Veterinární Medicína 55, No. 4 (May 19, 2010): 154–62. http://dx.doi.org/10.17221/38/2010-vetmed.

Pełny tekst źródła

Streszczenie:

The morphology and quality of oocytes is set during oo- and folliculo-genesis, and is completed during final maturation. Early embryonic development is associated with the morphology of the cumulus-oocyte-complex (COC). However, current knowledge of the possible relationships between oocyte morphology and the level of proteins within the oocyte, which may reflect fertilization ability, is insufficient. Using western-blot analysis and confocal microscopic observation, we determined the levels of integrin beta-2 (integrin &beta;2) and glycoprotein 3 (pZP3) protein levels in the porcine zona

Style APA, Harvard, Vancouver, ISO itp.

36

Gries, A., J. Nimpf, H. Wurm, G. M. Kostner та T. Kenner. "Characterization of isoelectric subspecies of asialo-β2-glycoprotein I". Biochemical Journal 260, № 2 (1 червня 1989): 531–34. http://dx.doi.org/10.1042/bj2600531.

Pełny tekst źródła

Streszczenie:

Isoelectric focusing of purified beta 2-glycoprotein I (beta 2-G-I) revealed five major bands with isoelectric points (pI) between 5.1 and 6.1. Neuraminidase treatment decreased the number of bands to two (pI 8.0 and 8.2). The two asialo subfractions of beta 2-G-I were purified by cation-exchange column chromatography. The more basic isoform II was found to have a higher content of lysine. Western-blot analysis of different plasma samples confirmed the heterogeneity of beta 2-G-I in plasma. Plasma treated with neuraminidase showed two bands irrespective of the number of isoforms as well as of

Style APA, Harvard, Vancouver, ISO itp.

37

Donald, A. S. R., and J. Feeney. "Oligosaccharides obtained from a blood-group-Sd(a+) Tamm-Horsfall glycoprotein. An n.m.r. study." Biochemical Journal 236, no. 3 (June 15, 1986): 821–28. http://dx.doi.org/10.1042/bj2360821.

Pełny tekst źródła

Streszczenie:

Treatment of Tamm-Horsfall urinary glycoprotein with Bacteroides fragilis endo-beta-galactosidase over a range of enzyme concentrations, pH and temperature resulted in the release of a small but constant proportion of the terminal sugars, which indicates the presence in the glycoprotein of relatively few enzyme-susceptible -GlcNAc beta 1-3Gal beta 1-4GlcNAc- units. Three oligosaccharides were isolated from the enzyme digest and characterized as Gal beta 1-4GlcNAc beta 1-3Gal, NeuAc alpha 2-3Gal beta 1-4 GlcNAc beta 1-3Gal and GalNAc beta 1-4(NeuAc alpha 2-3)Gal beta 1-4GlcNAc beta 1-3Gal by me

Style APA, Harvard, Vancouver, ISO itp.

38

TAKAMATSU, Kazunaga, Tadashi SUEHIRO, Masui KAWADA, and Fumitoshi OHNO. "Clinical Studies on Apolipoprotein H (β₂-glycoprotein I) in Patients with Hyperlipoproteinemia." Journal of Japan Atherosclerosis Society 15, no. 6 (1987): 1401–8. http://dx.doi.org/10.5551/jat1973.15.6_1401.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Brusch, Anna. "The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome." Antibodies 5, no. 2 (June 8, 2016): 16. http://dx.doi.org/10.3390/antib5020016.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Gang, Yong, Nobuhiko Kubo, Ikunosuke Sakurabayashi, Yoshihiko Ohtsuka, Jun Suzuki, Yasuhiro Nomata, and Tadashi Kawai. "Structural variety and biological function of apolipoprotein H (.BETA.2-glycoprotein I)." SEIBUTSU BUTSURI KAGAKU 38, no. 1 (1994): 1–5. http://dx.doi.org/10.2198/sbk.38.1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

BRIGHTON, Timothy A., Yan-Ping DAI, Philip J. HOGG, and Colin N. CHESTERMAN. "Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids." Biochemical Journal 340, no. 1 (May 10, 1999): 59–67. http://dx.doi.org/10.1042/bj3400059.

Pełny tekst źródła

Streszczenie:

Considerable interest is currently focused on the interactions of beta-2 glycoprotein I (β2GPI) and anti-phospholipid antibodies with anionic phospholipids in an attempt to understand the association between these antibodies and clinical diseases such as thrombosis. The interactions of β2GPI and anionic phospholipids have only been characterized partially, and the physiological role of this glycoprotein remains uncertain. In this study we have explored in detail the physical and phospholipid-binding characteristics of a number of β2GPI preparations. We have found (i) that perchloric acid-purif

Style APA, Harvard, Vancouver, ISO itp.

42

Mankaï, A., A. Achour, Y. Thabet, W. Manoubia, W. Sakly, and I. Ghedira. "Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease." Pathologie Biologie 60, no. 5 (October 2012): 291–95. http://dx.doi.org/10.1016/j.patbio.2011.07.003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Alarcon, Marcelo, Eduardo Fuentes, Ximena Maldonado, Claudia Mardones, and Iván Palomo. "Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies." MethodsX 6 (2019): 986–92. http://dx.doi.org/10.1016/j.mex.2019.04.023.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Terashi, Hiromi, Shinichiro Uchiyama, Shiori Hashimoto, and Makoto Iwata. ".BETA.2-glycoprotein I polymorphism as a risk factor for cerebral infarction." Nosotchu 27, no. 4 (2005): 608–11. http://dx.doi.org/10.3995/jstroke.27.608.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

BRIGHTON, Timothy A., Yan-Ping DAI, Philip J. HOGG, and Colin N. CHESTERMAN. "Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids." Biochemical Journal 340, no. 1 (May 15, 1999): 59. http://dx.doi.org/10.1042/0264-6021:3400059.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Cabral, A. R., and D. Alarcon-Segovia. "Anti-beta 2-glycoprotein I antibody testing in patients with antiphospholipid syndrome." Rheumatology 36, no. 11 (November 1, 1997): 1235. http://dx.doi.org/10.1093/rheumatology/36.11.1235.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Hasdemir, Hale S., and Emad Tajkhorshid. "Characterization of Beta-2-Glycoprotein I Domain V interaction with Plasma Membrane." Biophysical Journal 120, no. 3 (February 2021): 47a—48a. http://dx.doi.org/10.1016/j.bpj.2020.11.530.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Matsuura, E., Y. Igarashi, T. Yasuda, D. A. Triplett, and T. Koike. "Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface." Journal of Experimental Medicine 179, no. 2 (February 1, 1994): 457–62. http://dx.doi.org/10.1084/jem.179.2.457.

Pełny tekst źródła

Streszczenie:

Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipid syndrome (APS) directly bind to beta 2-glycoprotein I (beta 2-GPI), which is adsorbed to an oxidized polystyrene surface. Oxygen atoms were introduced on a polystyrene surface by irradiation with electron or gamma-ray radiation. X-ray photoelectron spectroscopy revealed the irradiated surfaces were oxidized to generate C-O and C = O moieties. aCL derived from either APS patients or (NZW x BXSB)F1 mice bound to beta 2-GPI coated on the irradiated plates, depending on the radiation dose. Antibod

Style APA, Harvard, Vancouver, ISO itp.

49

Mitchell, E. J., K. Lee, and M. D. O'Connor-McCourt. "Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein." Molecular Biology of the Cell 3, no. 11 (November 1992): 1295–307. http://dx.doi.org/10.1091/mbc.3.11.1295.

Pełny tekst źródła

Streszczenie:

Transforming growth factor-beta (TGF-beta) is a potential mediator of placental trophoblast functions, including differentiation, hormone production, endometrial invasion, and immunosuppression. Equilibrium binding and affinity-labeling assays were used to investigate the binding characteristics of TGF-beta 1 and TGF-beta 2 on an established human choriocarcinoma trophoblastic cell line (BeWo). The equilibrium binding experiments indicated that the BeWo cells exhibited similar average affinities and total number of binding sites for TGF-beta 1 and TGF-beta 2. The Kd values obtained from Scatch

Style APA, Harvard, Vancouver, ISO itp.

50

Atsumi, T., M. Khamashta, P. R. J. Ames, K. Ichikawa, T. Koike, and G. R. V. Hughes. "Protein S, C4b-binding protein (C4BP) and beta 2-glycoprotein I (??2-GPI) binding interaction." Blood Coagulation & Fibrinolysis 6, no. 6 (September 1995): 594. http://dx.doi.org/10.1097/00001721-199509000-00027.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!